Learning Objectives:

1. Discuss prevalence Non-alcoholic Fatty Liver Disease (NAFLD) and its natural history

2. Discuss the clinical presentation and evaluation process as directed by the NASPGHAN guidelines

3. Update on treatment modalities available for children with NAFLD

Session date: 
02/20/2020 - 12:00pm to 1:00pm CST
ucmc P-117
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ruba K. Azzam, MD, MPH